Quarterly report · Q2
4188.TEDINET S100PK3O
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.27T | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.16T | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.89T | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥956.8bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥118.4bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥50.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥153.1bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥66.1bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥122.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥46.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥147.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥73.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥29.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥85.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥35.2bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥91.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥38.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥101.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.7bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.00T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥5.57T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.32T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.96T | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.73T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.04T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.67T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.57T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.63T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.32T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥253.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥257.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥93.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥166.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥117.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥107.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥15.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥151.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥52.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥20.44 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥59.94 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥24.8 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥49.79 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.58 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥55.13 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.82 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 27.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.8% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥205.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥108.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥96.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥6.6bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥6.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥771.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥745.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥26.0bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥22.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥212.3bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥212.0bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥309m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥573.7bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥569.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥54.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥659.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥634.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥42.3bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.22T |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.16T |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥56.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥122.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.42T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.27T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥152.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥129.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥172.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥81.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥90.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥7.3bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥614.8bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥593.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥20.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥62.2bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥198.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥198.5bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥171m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥447.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥444.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥48.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥592.2bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥566.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥45.8bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.85T |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.80T |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥49.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥157.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.03T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.89T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥163.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 950
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYTDDuration | -117656000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -128781000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YTDDuration | -151409000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | CurrentYTDDuration | 15646000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | -336283000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 257652000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 253703000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 245789000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1506288107 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1506288107 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1506288107 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1506288107 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 218306000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1533 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 145159000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1019 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 85335000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0599 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 64389000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0452 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 42509000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0298 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 22843000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0160 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 22176000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0156 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 18838000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0132 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 18159000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0127 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 15526000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0109 | |
| Number of shares held | CurrentQuarterInstant | 653241000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4586 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 81880100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 175100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 14214776 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1421477600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 2755307 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 1506288107 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 14214776 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 81880100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 81880100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0544 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row2Member | 2400 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |